PHARLYSE SA has a total of 17 patent applications. Its first patent ever was published in 1983. It filed its patents most often in EPO (European Patent Office), Luxembourg and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ERCO LAEKEMEDEL AB, WANG SHENJIAN and MA XUEYING.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Luxembourg | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Belgium | 1 | |
#6 | Canada | 1 | |
#7 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Unspecified technologies | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Baudier Philippe | 12 |
#2 | Maes Paul | 7 |
#3 | Vanderbist Francis | 5 |
#4 | Fossion Jacques | 5 |
#5 | Deboeck Arthur Marie | 4 |
#6 | De Boeck Arthur | 4 |
#7 | Baudier Philippe Raymond | 3 |
#8 | De Boeck Arthur Marie | 2 |
#9 | Fossion Jacques Jean | 2 |
#10 | Maes Paul Jose | 2 |
Publication | Filing date | Title |
---|---|---|
EP0876814A1 | Dry powder inhaler excipient, process for its preparation and pharmaceutical compositions containing it | |
EP0591424A1 | Extended-release form of diltiazem | |
EP0349514A1 | Prolonged-release pharmaceutical composition containing erythromycine, its preparation and its use | |
LU87233A1 | Pharmaceutical composition based on a non-steroidal anti-inflammatory, preparation method and use thereof | |
BE1000381A4 | PHARMACEUTICAL PREPARATION BASED indomethacin. | |
EP0217778A2 | Galenical forms for the sustained release of verapamil, their preparation and medicaments containing them | |
LU86077A1 | New galenic forms of verapamil, their manufacture and the medicinal products containing these new galenic forms | |
EP0092287A2 | Acetylcysteine salts, their preparation and use |